Market Overview
Size, share, and connected demand
- Brevintel analysis values the orthopedic software market at USD 419.5 million in 2025 ($420M), expanding from USD 444.3 million in 2026 to USD 782.6 million by 2035 ($783M) at a 7.3% CAGR.
- Headline cards list $420M, $783M, and 7.3%; growth is accelerating from the approximately 4.9% rate recorded during 2022–2024.
- BRAINLAB led with over 12% market share in 2025, while BRAINLAB, MEDSTRAT, Stryker, Zimmer Biomet, and Materialise collectively held 50%.
- The estimated gross driver contribution of 9.0%, offset by 1.7% of restraint drag, supports the 7.3% forecast CAGR.
- More than 53 million U.S. adults had diagnosed arthritis during 2019–2021, while injury-related emergency-department visits exceed 40 million annually in the United States.
- Cloud and web-based platforms accounted for approximately 63% of market revenue in 2025, reflecting preference for lower local infrastructure requirements across multisite care settings.
- Orthopedic providers are moving from isolated specialty applications toward connected clinical, imaging, procedural, and reimbursement workflows.
- The commercial opportunity is increasingly tied to whether software can move information across these workflows without adding administrative burden or disrupting the operating room.
Market Dynamics
Interoperability and care-setting shift
- Full electronic health information compliance obligations and FHIR Bulk Data API requirements became active in late 2022 under the ONC Cures Act Final Rule.
- CMS Promoting Interoperability represents 25% of an eligible clinician's MIPS final score, making certified EHR capability financially relevant for Medicare-participating practices.
- Brevintel analysis finds that the 2022 deadline transition likely tempered historical growth as providers sequenced upgrades, integration work, and certification decisions.
- The World Health Organization estimates that musculoskeletal conditions affect approximately 1.71 billion people globally, creating a substantial underlying care burden.
- Orthopedic outpatient cases performed in ambulatory surgical centers increased 84% between 2022 and 2023, increasing the need for standardized preoperative planning and rapid postoperative handoffs.
- Technology investment is increasingly directed toward software that links planning, navigation, imaging, and clinical records rather than disconnected specialty tools.
- FHIR-based interoperability requirements heighten the value of products that can exchange usable data with certified health IT systems.
- Improved surgical precision and lower revision risk remain central adoption drivers where navigation, templating, and outcome documentation support procedure standardization.
Reliability, recalls, and cost
- Software malfunction risk creates a procurement hurdle distinct from ordinary IT implementation because errors in surgical guidance or planning can affect clinical decisions.
- FDA recall records include 2024 Class II recalls involving Stryker Blueprint and Mako software, as well as a 2023 recall involving Smith & Nephew's CORI RI.KNEE software.
- A systematic review of software-related recalls in computer-assisted hip and knee arthroplasty identified 11 recalls from 2017 to 2022, involving 4,634 units.
- Software design was identified as the root cause in 66.6% of reviewed events, lengthening validation cycles and increasing the importance of post-market surveillance.
- Server-based digital templating has been associated with initial institutional costs of USD 50,000–100,000, in addition to annual licensing costs of approximately USD 15,000.
- Labor is frequently the largest cost component in clinical decision-support implementation because systems must be configured, governed, maintained, and incorporated into care workflows.
- The result is a two-tier adoption pattern in which integrated health systems can justify enterprise investment while smaller providers prioritize modular or cloud-delivered tools.
- Brevintel analysis indicates that clinical demand does not automatically translate into rapid software adoption when hospital technology committees must still assess reliability, interoperability, and governance.
Segmentation Analysis
Product type
- EHR software is the largest and fastest-growing product category, projected to expand at an 8.5% CAGR from USD 148.0 million in 2025 to USD 303.9 million by 2035.
- EHR growth is supported by orthopedic-specific documentation, injury tracking, implant records, and the regulatory need for interoperable certified health IT.
- PACS software is projected to grow at a 7.6% CAGR as orthopedic care remains highly dependent on access to high-resolution radiographic, CT, and MRI images.
- Revenue-cycle-management software is expected to record a 6.8% CAGR because orthopedic procedures often involve detailed coding, implant documentation, payer authorization, and claims management.
- Practice-management software is projected to grow at a 5.4% CAGR.
- Digital templating and preoperative-planning software is expected to expand at a 5.1% CAGR.
- EHR adoption among orthopedic providers rose from 8% before HITECH to 46% during the incentive period and 51% during the subsequent penalty phase.
- Brevintel analysis attributes the 8.5% EHR CAGR versus the 5.1% digital-templating rate to the difference between mandated workflow infrastructure and elective clinical enhancement.
Delivery mode and application
- Cloud and web-based solutions represented approximately USD 266 million, or 63%, of the global market in 2025, supporting multisite access, software updates, and centralized administration.
- On-premises software is projected to reach USD 243.9 million by 2035, growing at a slower 5.4% CAGR among organizations with legacy infrastructure or complex internal integration requirements.
- Orthopedic surgeries represented USD 171.9 million in 2025, making them the leading application category for perioperative planning, documentation, imaging, navigation, and workflow coordination.
- Fracture management is projected to reach USD 223.1 million by 2035 at a 7.2% CAGR because trauma cases require timely image review, classification, treatment coordination, and follow-up.
- Joint-replacement applications are projected to reach USD 163.7 million by 2035, advancing at a 6.8% CAGR amid aging populations, robotic assistance, implant planning, and outcomes monitoring.
- Other applications are projected to reach USD 58.7 million by 2035 at a 6.0% CAGR.
End use
- Hospitals accounted for approximately USD 273 million, or 65%, of the market in 2025, with scale that supports enterprise EHR, PACS, operating-room, and analytics integration.
- Ambulatory surgical centers are projected to reach USD 202.2 million by 2035 at a 6.1% CAGR, supported by outpatient orthopedic growth.
- Other end users are projected to reach USD 40.6 million by 2035, growing at a 4.8% CAGR.
- ASC buyers prefer systems that can deliver planning and operational functionality without extensive local infrastructure.
Regional Outlook
North America
- North America is the largest regional market and is projected to expand from USD 137.9 million in 2021 to USD 294.6 million by 2035 at a 6.83% CAGR.
- The United States remains the principal revenue contributor, growing from USD 127.0 million to USD 268.4 million over the period.
- Canada is projected to grow faster, at a 7.85% CAGR, reflecting a lower starting base and continued digital-health investment.
- Cloud deployment in North America is projected to rise from USD 97.9 million in 2022 to USD 221.9 million by 2035, compared with on-premises growth from USD 45.5 million to USD 72.6 million.
- EHR software is expected to remain the largest regional product category, expanding from USD 55.2 million in 2022 to USD 126.9 million in 2035.
- Regulatory interoperability requirements, advanced hospital IT infrastructure, and a large orthopedic procedure base support adoption.
Europe and Asia Pacific
- Europe is projected to expand from USD 106.1 million in 2021 to USD 234.3 million by 2035, representing a 7.13% CAGR.
- Germany, the United Kingdom, and France provide important demand centers for surgical planning, imaging, and orthopedic workflow software.
- Asia Pacific is forecast to grow from USD 74.4 million in 2021 to USD 190.0 million by 2035, the fastest regional CAGR at 8.37%.
- The region represented approximately USD 93.5 million, or 22%, of global market revenue in 2025.
- The Western Pacific and South-East Asia regions together account for roughly 796 million people living with musculoskeletal conditions, based on World Health Organization estimates.
- Asia Pacific also had approximately 722 million people aged 60 years or older in 2024, and that share is expected to rise from about 15% to 26% by 2050.
- Brevintel analysis notes that Asia Pacific's 8.37% CAGR is 104 basis points above North America's 6.83% rate, leaving room for software adoption as health systems expand orthopedic capacity.
- Approximately 30% of Japan's population is aged 65 years or older, and Intellijoint Surgical received Japanese regulatory approval for Intellijoint KNEE in March 2024.
- The orthopedic device market grew 6.3% to USD 59 billion in 2023, with Asia Pacific joint-replacement recovery contributing to the expansion.
- China and India offer large procedure and aging-population bases, while Japan, Australia, and South Korea provide more mature digital-health and surgical-technology environments.
Latin America and Middle East & Africa
- Latin America is projected to increase from USD 16.3 million in 2021 to USD 38.1 million by 2035 at a 7.59% CAGR, with Brazil, Mexico, and Argentina as the primary markets.
- Road injuries, sports injuries, orthopedic disorders, and private healthcare expansion support demand, although buyers frequently require modular offerings with manageable implementation cost.
- The Middle East and Africa market is expected to grow from USD 11.3 million in 2021 to USD 25.7 million by 2035, at a 7.37% CAGR.
- Higher-income Middle Eastern markets are investing in specialized hospitals, medical tourism, spine surgery, deformity correction, and joint reconstruction, while many sub-Saharan markets remain at an early stage of digital-health adoption.
- Suppliers must balance enterprise capability with the operating constraints of hospitals that have limited integration resources.
Competitive Landscape
Structure and workflow integration
- The top five participants collectively account for approximately 50% of market revenue, indicating meaningful concentration while leaving room for specialty vendors with differentiated clinical workflows.
- Competition is shaped less by standalone software features than by the ability to integrate imaging, planning, navigation, documentation, and enterprise data systems.
- BRAINLAB connects planning, imaging, and intraoperative information and has been deployed across 6,300 hospitals in 120 countries through its broader navigation footprint.
- Materialise positions its Mimics platform around patient-specific visualization and 3D planning capabilities.
- BRAINLAB, Stryker, Zimmer Biomet, Intellijoint Surgical, and Materialise compete most visibly where surgical planning, guidance, navigation, and patient-specific visualization overlap.
- GE HealthCare, Philips, Siemens Healthineers, Carestream, Esaote, Merative, and McKesson have advantages in enterprise imaging, health IT, distribution, or installed customer relationships.
- MEDSTRAT's position is more closely associated with real-world data, outcomes research, and population-level analytics, while Surgimap focuses on specialist planning applications.
- AI-assisted planning, robotics, cloud delivery, and interoperability are the principal competitive directions, converting fewer manual handoffs and faster image-to-plan cycles into measurable workflow value.
Surgical planning and navigation
- BRAINLAB
- Stryker
- Zimmer Biomet
- Intellijoint Surgical
- Materialise
Enterprise imaging and analytics
- GE HealthCare
- Philips
- Siemens Healthineers
- Carestream
- Esaote
- MEDSTRAT
- Merative
- McKesson
- Surgimap